what is glp-1 cost A comparison of receptor agonists and bariatric surgery: the break even point? | Surgical Endoscopy Breaking Down the Cost of

While concerns have been raised at the sheer cost of medicating obesity to the healthcare system the National Health Service (NHS) in the UK currently only covers Wegovy for a two-year period the coming wave of lower-cost generic alternatives could make this more viable

Overweight Adults with Related Health Conditions: Patients with a BMI of 27 or above who also have at least one weight-related condition, such as type 2 diabetes, high blood pressure, or high cholesterol

V., Marina, A

That number is not just large in absolute terms, it is the largest weight-loss signal ever reported in a randomized Phase 3 trial of a GLP-1-class compound, and it arrived with additional secondary findings that reframe what "GLP-1 therapy" could eventually mean: a 75.8% reduction in osteoarthritis pain, a roughly 20% drop in LDL cholesterol, and a 72% reversal rate of prediabetes to normoglycemia in the affected subpopulation